ABSTRACT
INTRODUCTION
he prevalence of type 2 diabetes (T2D) has tripled in the last 30 years. [1] Currently, T2D afflicts more than 20 million people in the United States. [2] Although T2D is a heterogeneous disease, most patients with T2D have insulin resistance and the metabolic syndrome before the onset of T2D. [3] In fact, insulin resistance, hyperinsulinemia, dyslipidemia, and obesity precede the progression to T2D in 75% to 85% of patients. [4] The presence of the metabolic syndrome increases the risk and is highly predictive of new onset T2D. [5] The metabolic syndrome (syndrome X), also called "insulin resistance syndrome" is a cluster of disorders including central obesity, atherogenic dyslipidaemia, hypertension, impaired glucose tolerance as well as thrombotic and proinflammatory states. [6] [7] [8] [9] That collection of diseases is associated with an increased risk of development of atherosclerosis, T2D and cardiovascular disease, thrombotic events and all-cause mortality. [10] [11] [12] It affects one in five people, and prevalence increases with age. Some studies estimate the prevalence of the metabolic syndrome in the United States to be up to 25% of the population. [13] It has been observed that the risk for incident T2D is up to 5 fold higher in individuals with the metabolic syndrome compared with those without the syndrome. [14] The presence of both the metabolic syndrome and insulin resistance has an additive effect, as these patients exhibit a 6-7 fold an increased risk for T2D. [15] This study was an attempt to evaluate the association between T2D and the metabolic syndrome and to evaluate the impact of the metabolic syndrome in T2D patients. [7, 16] Blood samples were collected in a fasting state and used for the estimation of fasting blood glucose (FBG) level and lipid parameters. FBG, triglycerides (TG) and high density lipoprotein-cholesterol (HDL-C) levels were estimated by enzymatic methods using kits from (Biocon for FBG, and Human for both TG and HDL-C). Statistical analysis was performed using SPSS program (version 16). The statistical differences was established by using the student's and Chi-square (X 2 ) tests.
PATIENTS AND METHODS
P<0.05 was considered to be statistically significant. (Table- 2), the frequencies of the metabolic syndrome were significantly higher in male and female patients with T2D (75.6% and 94.2% respectively) in comparison to male and female control subjects (8.6% and 8.0% respectively), (P<0.001). Values are given in mean( SD). *: P < 0.05, **: P < 0.01 ,***: P < 0.001 (T2D patients vs controls) 
RESULTS

DISCUSSION
Diabetes is the most significant metabolic disease as it leads to a broad spectrum of microvascular and macrovascular complications including end-stage vascular disease, cardiovascular damage and retinopathy. Consequently, a large burden is imposed on the national health system of countries all over the world. [17] T2D, which accounts for 90 per cent of all diabetes, has become one of the major causes of premature morbidity and mortality, mainly via the increased risk of cardiovascular disease which is responsible for up to 80 per cent of these deaths. [18] The clinical significance of the metabolic syndrome arises from its association with T2D and cardiovascular disease. [17] Metabolic syndrome in people with T2D, appear to confer a substantial additional health risks particularly cardiovascular risk over and above the sum of the risk associated with each single abnormality. [19] The present study revealed a remarkably higher frequency of the metabolic syndrome among T2D patients in either sex in comparison to their respective controls. Among diabetics, the frequency of the metabolic syndrome was even more higher among females than males. This could be explained by increased prevalence of obesity in women as a result of several cultural and social factors such us multiple pregnancies, high unemployment, over eating and physical inactivity. [20, 21] These results are in agreement with the observation of others. [22] [23] [24] [25] The higher frequency of the metabolic syndrome in T2D patients reported in this study could be, at least partly, also attributed to stressful factors to which our patients are exposed to. Chronic psychosocial stress may lead to chronic excess cortisol, which in turn may play a role in the pathogenesis of the metabolic syndrome. [26] The present study demonstrated that the major metabolic syndrome determinants in T2D patients were BP, HDL-C and WC in males, and WC, TG and in females HDL-C respectively. Central obesity measured by WC was found by the present study to be a major determinant for the development of the metabolic syndrome among diabetic male and female patients. This could be due to sedentary life style and lack of physical activity. [27] This is in agreement with other studies. [24, 28] It has been found that, among the five components of the ATP III criteria, waist circumference was the single most common parameter to likely meet the metabolic syndrome criteria. [29] Similarly, a low HDL-C level is also found to be a significant metabolic syndrome determinant in diabetic patients in either sex. Reduced HDL-C is a major independent cardiovascular risk factor of atherogenic dyslipidaemia, as HDL-C protects against an increase in TG or LDL-C levels. [30, 31] The same finding was observed by others. [24, 28] An elevated BP level was a significant metabolic syndrome determinant in T2D male patients, however it was non-significantly elevated among female patients. The insulin resistance can directly affect vascular signaling, eventually leading to proliferation of smooth muscle cells in the vessel wall and increased rates of intimal expansion and eventually a high BP. [32] This is in agreement with others. [24] In addition, obese people tend to have an elevated BP compared with lean people. [6] An elevated TG level was a significant determinant of the metabolic syndrome in diabetic female patients, however it was non-significantly higher among male patients with the metabolic syndrome. This observation is similar to that of others. [24, 28] The high TG level in association with the metabolic syndrome could due to the presence of insulin resistance. Lipolysis in adipocytes is enhanced, plasma concentrations of free fatty are transported to liver and muscle. In the liver, some are oxidized, and most are re-esterified to form TG. At the same time, insulin drives lipogenesis in the liver directly. Elevated plasma glucose concentrations may also increase hepatic TG synthesis by providing the carbon skeleton for glycerol.
[33] Furthermore, LDL particles occurs in association with the metabolic syndrome and atherogenic dyslipidaemia tend to be small and dense 6. and are more atherogenic. [34] [35] [36] It has been suggested that nondiabetic persons with the metabolic syndrome are at a substantial risk for the development of T2D. The risk of T2D is up to 5 fold higher in patients with the metabolic syndrome.
[37] In addition, the greatest impact of T2D is the 2-4 times greater risk of coronary heart disease and cerebrovascular disease.
[38] Furthermore, the more components of the metabolic syndrome that are accumulated, the higher is the cardiovascular mortality rate. [39] We conclude that patients with T2D have a distinctly high frequency of the metabolic syndrome. Thus, they are at a considerably risk of atherosclerotic cardiovascular disease and cerebrovascular disease, and their clinical complications.
